Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05658302

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University of Minnesota · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers

Summary

This study will help us better understand how the brain works in people with Parkinson's disease (PD). PD is a brain disease that gets worse over time, and affects over 10 million people world-wide. A common treatment for PD is Deep Brain Stimulation (DBS). To improve DBS therapy for PD, we need a deeper understanding of how the different parts of the brain work together in PD, and how this relates to movement and thinking problems that people with PD experience. We may be able to use the results of this study to improve DBS treatments in the future.

Detailed description

Parkinson's disease (PD) is a progressive neurodegenerative disease affecting over 10 million people world-wide. It can be a debilitating disorder and although studied for decades, the physiological changes in the basal ganglia thalamocortical (BGTC) circuit that underlie its development remain under debate. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and internal globus pallidus (GPi) has been a highly effective therapy for many patients with PD, however, the results have been highly variable and may be associated with cognitive compromise in some patients. To advance DBS therapies for PD we require a deeper understanding of the local and network-wide circuit dynamics and their relationship to motor signs and cognitive function. This understanding will provide the rationale for optimizing STN and GPi DBS, targeting specific regions within the STN and GPi, and development of patient-specific DBS based on the patients' motor signs and cognitive profile

Conditions

Timeline

Start date
2023-03-28
Primary completion
2027-03-01
Completion
2028-03-01
First posted
2022-12-20
Last updated
2026-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05658302. Inclusion in this directory is not an endorsement.